Showing results (1961-1970 of 2,317) with videos related to

Sort By:
Pageof 232
Healthcare (Basel, Switzerland)|October 13, 2023
Cross-Cultural Adaptation and Psychometric Properties of the Traditional Chinese Version of the Italian Spine Youth Quality of Life (ISYQOL) QuestionnaireAva Ying Cheng, Pik Kwan Jim, Ning Wai Kwan, et al.
Cancer Science|September 5, 2020
Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survivalShu-Kui Qin, Qing Li, Jian Ming Xu, et al.
Thoracic Cancer|January 23, 2019
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303Xiaoyan Si, Li Zhang, Hanping Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2020
Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitorsYing Cheng, Lixia Ma, Ying Liu, et al.
ACS Applied Materials & Interfaces|September 7, 2022
Abundant (110) Facets on PdCu3 Alloy Promote Electrochemical Conversion of CO2 to COJianwu Dong, Ying Cheng, Ying Li, et al.
Cell & Bioscience|June 27, 2024
Generation and transcriptomic characterization of MIR137 knockout miniature pig model for neurodevelopmental disordersShengyun Xu, Jiaoxiang Wang, Kexin Mao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 4, 2016
Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroupJen-Chieh Lee, Tzu-Pin Lu, Chun A Changou, et al.
Future Oncology (London, England)|November 9, 2020
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050Jean Paty, Rickard Sandin, Arlene Reisman, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2020
Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib: Results from ASCEND-6Yi-Long Wu, Yuankai Shi, Daniel Shao Weng Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)Qing Zhou, Cai-cun Zhou, Gong-yan Chen, et al.
Pageof 232